BWAY - BrainsWay launches noninvasive treatment for smoking addiction

BrainsWay (BWAY) announces the distribution of its first 10 Deep Transcranial Magnetic Stimulation ((Deep TMS)) devices for smoking addiction to practices across the United States.Deep TMS is the first FDA-cleared noninvasive treatment in the addiction space for any TMS device, and currently serves as the only TMS platform technology with clinical outcome data for multiple brain disorders.BrainsWay announced that the U.S. FDA granted 501k clearance for the company’s Theta Burst three-minute protocol utilizing its proprietary Deep TMS system for the treatment of major depressive disorder ((MDD)), earlier this week.Shares down marginally during premarket trading.

For further details see:

BrainsWay launches noninvasive treatment for smoking addiction